Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
54.25
+0.88 (1.65%)
May 12, 2026, 1:07 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg Revenue
6.95B6.82B5.99B
MedSurg Revenue Growth
1.82%13.87%10.53%
Cardiovascular Revenue
13.67B13.25B10.76B
Cardiovascular Revenue Growth
3.16%23.20%21.95%
Revenue (Other)
-1.00M--1.00M
Revenue (Total)
20.62B20.07B16.75B
Revenue (Total) Growth
2.70%19.87%17.61%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
U.S Revenue
13.19B12.86B10.21B
U.S Revenue Growth
2.51%25.99%21.19%
Europe, Middle East and Africa Revenue
3.54B3.45B3.23B
Europe, Middle East and Africa Revenue Growth
2.46%6.91%13.03%
Asia-Pacific Revenue
3.18B3.08B2.69B
Asia-Pacific Revenue Growth
3.34%14.67%11.92%
Latin America and Canada Revenue
708.00M678.00M624.00M
Latin America and Canada Revenue Growth
4.42%8.65%11.43%
Revenue (Other)
1.00M1.00M-1.00M
Revenue (Total)
20.62B20.07B16.75B
Revenue (Total) Growth
2.70%19.87%17.61%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg Organic Revenue Growth
6.70%7.50%
Cardiovascular Organic Revenue Growth
20.80%21.90%
Total Organic Revenue Growth
15.80%16.40%
Updated May 1, 2026. Data Source: Fiscal.ai.